Report of termination of the clinical trial in the Czech Republic TUD-2DAUNO-058
| Authors | |
|---|---|
| Year of publication | 2020 |
| MU Faculty or unit | |
| Web | https://www.sukl.cz/modules/evaluation/detail.php?id=41660 |
| Attached files | |
| Description | EudraCT 2013-003191-12 Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia over 60 years. Clinical Trial Termination Information provides a comprehensive overview of clinical trial (KH) information. It describes the course of KH, including a brief description, lists KH centers and their principal investigators, and provides information on KH subjects (number of patients enrolled, number of patients who completed the study, and number of patients who did not complete it). It also contains safety information and monitored efficacy parameters, measures taken during KH, and information on audits performed. |
| Related projects: |